Medicinal plants like Asteraceae and Zingiberaceae combat amoebiasis (a parasitic infection). Discover the potent ...

The World Health Organization (WHO) has announced its recommendations for the 2026–2027 Northern Hemisphere influenza vaccine ...

Produced using Dyadic’s proprietary high-yield fungal microbial expression platforms and Fermbox Bio’s scale-up and biomanufacturing capabilities, Recombinant DNase I (RNase-free) is currently ...

In addition to OEM distribution, the collaboration provides flexibility for potential future expansion, which could include Dyadic supplying market-ready products for distribution or licensing ...

Dyadic Applied BioSolutions ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology company producing precision-engineered ...

In the ever changing biotherapeutics landscape, antibody-drug conjugates (ADCs) and monoclonal antibodies (mAbs) success ...

Allied Market Research published a report, titled, "Fibrinogen Concentrate Market by Product Type (Human Fibrinogen Concentrate, Re ...

Dublin, March 13, 2026 (GLOBE NEWSWIRE)-- The "Ngenla Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. The Ngenla ...

Built in 1902 to house an eccentric inventor’s rare plant collection, preserving this building in San Francisco has been a ...

In the volatile world of technology stocks, the goal is to stand alone as the market leader, or at the very least excel as a top competitor, with proven products capable of turning a profit while ...

Read more about Future pandemics may be fought faster with mRNA and advanced vaccine platforms on Devdiscourse ...

February 2026 saw a major biopharma acquisition, four key buyouts, and licensing deals in antibodies, small molecules, and ...